Social Pharmacology: A Further Step in Public Health

J. Alloza
{"title":"Social Pharmacology: A Further Step in Public Health","authors":"J. Alloza","doi":"10.2174/1874945301406010008","DOIUrl":null,"url":null,"abstract":"Social Pharmacology is a field of health science which generates knowledge about marketed drugs in actual use; it focuses on evaluation of the social consequences of an individual's exposure to any marketed drug and factors related to its utilization.. The goal of this discipline is to gain knowledge still needed after a drug is marketed. The dossier of a new medicine following regulatory approval contains only the beginning of information needed to be gathered. The postmarketing period represents the most extensive opportunity to study medications in their \"social life cycle\" The post- approval environment is complex: strict drug development process controls are no longer in place and operational and management actions by industrial sponsors, health delivery agencies and regulators are unpredictable. We review the impact of social pharmacology on public health in its broadest scope. Social pharmacology is proposed as a strategic means to obtain essential data about marketed drugs by engaging the expertise of heterogeneous groups of health-related disciplines., By assessing the wide scope of potential interactions between vectors linked to the actual use of marketed drugs, population-based conclusions may be reached about risk-benefit factors, need for alert responses, proposed actions for decision-making, importance of negative drug effects, and promotion of proper and efficient use of drugs .","PeriodicalId":285033,"journal":{"name":"The Open Social Science Journal","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Social Science Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874945301406010008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Social Pharmacology is a field of health science which generates knowledge about marketed drugs in actual use; it focuses on evaluation of the social consequences of an individual's exposure to any marketed drug and factors related to its utilization.. The goal of this discipline is to gain knowledge still needed after a drug is marketed. The dossier of a new medicine following regulatory approval contains only the beginning of information needed to be gathered. The postmarketing period represents the most extensive opportunity to study medications in their "social life cycle" The post- approval environment is complex: strict drug development process controls are no longer in place and operational and management actions by industrial sponsors, health delivery agencies and regulators are unpredictable. We review the impact of social pharmacology on public health in its broadest scope. Social pharmacology is proposed as a strategic means to obtain essential data about marketed drugs by engaging the expertise of heterogeneous groups of health-related disciplines., By assessing the wide scope of potential interactions between vectors linked to the actual use of marketed drugs, population-based conclusions may be reached about risk-benefit factors, need for alert responses, proposed actions for decision-making, importance of negative drug effects, and promotion of proper and efficient use of drugs .
社会药理学:公共卫生的进一步发展
社会药理学是健康科学的一个领域,它产生有关实际使用的上市药物的知识;它侧重于评估个人接触任何上市药物的社会后果和与其使用有关的因素。这门学科的目标是获得药物上市后仍然需要的知识。监管部门批准后的新药档案只包含需要收集的信息的开始部分。上市后时期是研究药物“社会生命周期”的最广泛的机会。批准后的环境是复杂的:严格的药物开发过程控制不再到位,工业赞助商、卫生服务机构和监管机构的操作和管理行动是不可预测的。我们在最广泛的范围内回顾社会药理学对公共卫生的影响。社会药理学被提议作为一种战略手段,通过参与与健康相关学科的异质群体的专业知识,获得有关已上市药物的基本数据。通过评估与上市药物实际使用相关的病媒之间潜在相互作用的广泛范围,可以得出基于人群的结论,包括风险-收益因素、警报反应的必要性、建议的决策行动、药物负面效应的重要性以及促进药物的正确和有效使用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信